Press Release: Angelini : Angelini Pharma Presents Long-Term Data for cenobamate Demonstrating Benefit in Adults Living with Epilepsy

ROME, ITALY, September 19, 2024 /⁨EINPresswire.com⁩/ -- - Findings from a post-hoc analysis of the C017 open-label extension (OLE) study demonstrated long-term reduction in seizure frequency with cenobamate, approved as adjunctive treatment in patients ...